Joseph Thakuria

Joseph Thakuria is a skilled leader in the clinical development of RNA, cell, and gene therapies. They held various prominent positions, including Senior Medical Director at Takeda, where they led the global clinical program for an anti-SARS-CoV-2 treatment, and Medical Director at Astellas Pharma, overseeing multiple drug development projects. Joseph also co-founded companies such as Veritas Genetics and Curoverse and has served as an instructor at Massachusetts General Hospital. They trained at prestigious institutions, including Harvard Medical School, where they received multiple fellowships and awards for their contributions to medical education and genetics. Currently, Joseph serves as Medical Director at Arrowhead Pharmaceuticals.